MindMaze Therapeutics Holding SA (V6M) Stock Statistics & Valuation Metrics
Total Valuation
MindMaze Therapeutics Holding SA has a market cap or net worth of EUR 28.97M. The enterprise value is EUR 25.46M.
- Market Cap
- EUR 28.97M
- Enterprise Value
- EUR 25.46M
Share Statistics
MindMaze Therapeutics Holding SA has 181,497,670 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 181,497,670
- Owned by Insiders
- ―
- Owned by Institutions
- 0.33%
Financial Efficiency
MindMaze Therapeutics Holding SA’s return on equity (ROE) is -0.47 and return on invested capital (ROIC) is -34.28%.
- Return on Equity (ROE)
- -0.47
- Return on Assets (ROA)
- -0.32
- Return on Invested Capital (ROIC)
- -34.28%
- Return on Capital Employed (ROCE)
- -0.39
- Revenue Per Employee
- 841.70K
- Profits Per Employee
- -1.71M
- Employee Count
- 10
- Asset Turnover
- 0.16
- Inventory Turnover
- 2.47
Valuation Ratios
The current PE Ratio of MindMaze Therapeutics Holding SA is -2.13. MindMaze Therapeutics Holding SA’s PEG ratio is -0.02.
- PE Ratio
- -2.13
- PS Ratio
- 8.95
- PB Ratio
- 1.11
- Price to FCF
- -10.59
- Price to Operating Cash Flow
- -10.65
- PEG Ratio
- -0.02
Income Statement
In the last 12 months, MindMaze Therapeutics Holding SA had revenue of 8.42M and earned -17.12M in profits. Earnings per share was -1.36.
- Revenue
- 8.42M
- Gross Profit
- 5.84M
- Operating Income
- -18.89M
- Pretax Income
- -19.36M
- Net Income
- -17.12M
- EBITDA
- -16.73M
- Earnings Per Share (EPS)
- -1.36
Cash Flow
In the last 12 months, operating cash flow was -3.40M and capital expenditures -26,000, giving a free cash flow of -3.43M billion.
- Operating Cash Flow
- -3.40M
- Free Cash Flow
- -3.43M
- Free Cash Flow per Share
- -0.27
Dividends & Yields
MindMaze Therapeutics Holding SA pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -9.45%
- Earnings Yield
- -47.05%
Stock Price Statistics
- Beta
- -19.21
- 52-Week Price Change
- -94.84%
- 50-Day Moving Average
- 0.17
- 200-Day Moving Average
- 0.41
- Relative Strength Index (RSI)
- 56.81
- Average Volume (3m)
- 2,942
Important Dates
MindMaze Therapeutics Holding SA upcoming earnings date is ―, Before Open (Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
MindMaze Therapeutics Holding SA as a current ratio of 3.95, with Debt / Equity ratio of 5.84%
- Current Ratio
- 3.95
- Quick Ratio
- 3.74
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.77
- Interest Coverage Ratio
- -273.70
Taxes
In the past 12 months, MindMaze Therapeutics Holding SA has paid -2.24M in taxes.
- Income Tax
- -2.24M
- Effective Tax Rate
- 0.12
Enterprise Valuation
MindMaze Therapeutics Holding SA EV to EBITDA ratio is -1.41, with an EV/FCF ratio of -7.49.
- EV to Sales
- 6.33
- EV to EBITDA
- -1.41
- EV to Free Cash Flow
- -7.49
- EV to Operating Cash Flow
- -7.55
Balance Sheet
MindMaze Therapeutics Holding SA has EUR 12.50M in cash and marketable securities with EUR 1.90M in debt, giving a net cash position of EUR 10.60M billion.
- Cash & Marketable Securities
- EUR 12.50M
- Total Debt
- EUR 1.90M
- Net Cash
- EUR 10.60M
- Net Cash Per Share
- EUR 0.06
- Tangible Book Value Per Share
- EUR 0.16
Margins
Gross margin is -29.03%, with operating margin of -204.88%, and net profit margin of -420.33%.
- Gross Margin
- -29.03%
- Operating Margin
- -204.88%
- Pretax Margin
- -489.96%
- Net Profit Margin
- -420.33%
- EBITDA Margin
- -449.51%
- EBIT Margin
- -489.64%